Encyclopedia of Systems Biology

2013 Edition
| Editors: Werner Dubitzky, Olaf Wolkenhauer, Kwang-Hyun Cho, Hiroki Yokota

Systems Pharmacology, Drug-Target Networks

  • Jose C. NacherEmail author
  • Jean-Marc Schwartz
Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-9863-7_576


Relationships between drugs and their molecular targets can be characterized in a comprehensive manner using interaction networks.


For many years, the dominant approach of drug design has focused on the search for highly selective ligands targeting a specific disease-causing agent. However, this reductionist approach is now being questioned as many drugs are failing in late clinical development stages. It is estimated that as much as 30% of newly developed drugs fail due to a lack of efficacy and a similar rate due to harmful side effects (Hopkins 2008).

Systems biology has challenged this view by raising awareness that no component or process is isolated in biological systems. This principle applies to diseases as well, since many genes are related to more than one disease, and the pharmacology of drug-disease interactions reveals intricate connections between heterogeneous classes of therapies ( Systems Pharmacology, Drug Disease Interactions).

A new...

This is a preview of subscription content, log in to check access.


  1. Berger SI, Iyengar R (2009) Network analyses in systems pharmacology. Bioinformatics 25:2466–2472PubMedCrossRefGoogle Scholar
  2. Dalkic E, Wang X, Wright W, Chan C (2010) Cancer-drugs associations: a complex system. PLoS One 5:e10031PubMedCrossRefGoogle Scholar
  3. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL (2007) The human disease network. Proc Natl Acad Sci USA 104:8685–8690PubMedCrossRefGoogle Scholar
  4. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682–690PubMedCrossRefGoogle Scholar
  5. Ma’ayan A, Jenkins SL, Goldfarb J, Iyengar R (2007) Network analysis of FDA approved drugs and their targets. Mt Sinai J Med 74:27–32PubMedCrossRefGoogle Scholar
  6. Nacher JC, Schwartz JM (2008) A global view of drug-therapy interactions. BMC Pharmacol 8:5PubMedCrossRefGoogle Scholar
  7. Schwartz JM, Nacher JC (2009) Local and global modes of drug action in biochemical networks. BMC Chem Biol 9:4PubMedCrossRefGoogle Scholar
  8. Shiwen Z, Li S (2010) Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One 5:e11764CrossRefGoogle Scholar
  9. Spiro Z, Kovacs IA, Csermely P (2008) Drug therapy networks and the prediction of novel drug targets. J Biol 7:20PubMedCrossRefGoogle Scholar
  10. Yıldırım MA, Goh KI, Cusick ME, Barabási AL, Vidal M (2007) Drug-target network. Nat Biotechnol 25:1119–1126PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.Department of Information ScienceFaculty of Science, Toho UniversityFunabashiJapan
  2. 2.Manchester Institute of BiotechnologyFaculty of Life Sciences, University of ManchesterManchesterUK